Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2020

23.04.2019 | Nerve Injury

Long-term outcomes of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation in Chinese patients

verfasst von: Ngai-Yin Chan, Chi-Chung Choy, Ho-Chuen Yuen, Hoi-Fan Chow, Ho-Fai Fong

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to study the long-term outcomes of cryoballoon (CB) pulmonary vein isolation (PVI) in treating Chinese patients with atrial fibrillation (AF).

Methods

A total of 122 patients (48 women, mean age 57.4 ± 11.3) underwent CB PVI (first generation CB 44.3%, second generation CB 55.7%) for AF (paroxysmal 65.6%, persistent 10.7% and long-standing persistent 23.8%).

Results

PVI was achieved in 113 (92.6%) patients with CB alone, and it was achieved in all patients with additional touch-up by 8-mm-tip cryocatheter. The mean procedural and fluoroscopic duration were 171.9 ± 41 and 46.6 ± 14.6 min respectively. The recurrence-free survival for paroxysmal and non-paroxysmal AF was 77% and 59% respectively at 1 year and progressively declined over time to reach a plateau of 52% and 30% for paroxysmal and non-paroxysmal AF respectively at 5 years. In patients undergoing PVI with second-generation CB, the recurrence-free survival was 75% for paroxysmal AF and 45% for non-paroxysmal AF at 5 years. With multivariate Cox regression analysis, the types of CB (use of second-generation CB: HR 0.49; 95% CI 0.28–0.85; p = 0.011) and size of left atrium (LA) (larger LA size: HR 1.52; 95% CI 1–2.14; p = 0.017) independently predicted recurrence. Transient phrenic nerve injury (PNI) occurred in four (3.3%) patients and persistent PNI occurred in four (3.3%) patients. Other complications occurred in 10 (8.2%) patients with no procedure-related death.

Conclusions

Long-term success of CB PVI for AF declined over time and reached a plateau at 5 years. CB types and LA size are independent predictors for long-term recurrence.
Literatur
1.
Zurück zum Zitat Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, et al. STOP AF Cryoablation investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61:1713–23.CrossRef Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, et al. STOP AF Cryoablation investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61:1713–23.CrossRef
2.
Zurück zum Zitat Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nolker G. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol. 2013;61(16):1707–12.CrossRef Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nolker G. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol. 2013;61(16):1707–12.CrossRef
3.
Zurück zum Zitat Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, et al. FIRE AND ICE investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.CrossRef Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, et al. FIRE AND ICE investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.CrossRef
4.
Zurück zum Zitat Kuck KH, Furnkranz A, Chun KRJ, Metzner A, Ouyang F, Schluter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858–65.CrossRef Kuck KH, Furnkranz A, Chun KRJ, Metzner A, Ouyang F, Schluter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37:2858–65.CrossRef
6.
Zurück zum Zitat Mondesert B, Andrade JG, Khairy P, Guerra PG, Dyrda K, Macle L, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:605–11.CrossRef Mondesert B, Andrade JG, Khairy P, Guerra PG, Dyrda K, Macle L, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:605–11.CrossRef
7.
Zurück zum Zitat Miyazaki S, Nakamura H, Taniguchi H, Takagi T, Iwasawa J, Watanabe T, et al. Esophagus-related complications during second-generation cryoballoon ablation-insight from simultaneous esophageal temperature monitoring from 2 esophageal probes. J Cardiovasc Electrophysiol. 2016;27:1038–44.CrossRef Miyazaki S, Nakamura H, Taniguchi H, Takagi T, Iwasawa J, Watanabe T, et al. Esophagus-related complications during second-generation cryoballoon ablation-insight from simultaneous esophageal temperature monitoring from 2 esophageal probes. J Cardiovasc Electrophysiol. 2016;27:1038–44.CrossRef
8.
Zurück zum Zitat Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, et al. Antithrombotic management in patients undergoing electrophysiological procedures. A European Heart Rhythm Association (EHRA) position document endorsed by the ESC working group thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2015;17:1197–214.CrossRef Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, et al. Antithrombotic management in patients undergoing electrophysiological procedures. A European Heart Rhythm Association (EHRA) position document endorsed by the ESC working group thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2015;17:1197–214.CrossRef
9.
Zurück zum Zitat Chan NY. Catheter ablation of peri-nodal and pulmonary veno-atrial substrates: should it be cool? Europace. 2015;17(Suppl 2):ii19–30.CrossRef Chan NY. Catheter ablation of peri-nodal and pulmonary veno-atrial substrates: should it be cool? Europace. 2015;17(Suppl 2):ii19–30.CrossRef
10.
11.
Zurück zum Zitat Brooks S, Metzner A, Wohlmuth P, Lin T, Wissner E, Tilz R, et al. Insights into ablation of persistent atrial fibrillation: lessons from 6-year clinical outcomes. J Cardiovasc Electrophysiol. 2018;29:257–63.CrossRef Brooks S, Metzner A, Wohlmuth P, Lin T, Wissner E, Tilz R, et al. Insights into ablation of persistent atrial fibrillation: lessons from 6-year clinical outcomes. J Cardiovasc Electrophysiol. 2018;29:257–63.CrossRef
12.
Zurück zum Zitat Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, et al. Catheter ablation of long-standing persistent atrial fibrillation. J Am Coll Cardiol. 2012;60:1921–9.CrossRef Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, et al. Catheter ablation of long-standing persistent atrial fibrillation. J Am Coll Cardiol. 2012;60:1921–9.CrossRef
13.
Zurück zum Zitat Heeger CH, Wissner E, Knoll M, Knoop B, Reissmann B, Mathew S, et al. Three-year clinical outcome after 2nd-generation cryoballoon-based pulmonary vein isolation for the treatment of paroxysmal and persistent atrial fibrillation- a 2-center experience. Circ J. 2017;81:974–80.CrossRef Heeger CH, Wissner E, Knoll M, Knoop B, Reissmann B, Mathew S, et al. Three-year clinical outcome after 2nd-generation cryoballoon-based pulmonary vein isolation for the treatment of paroxysmal and persistent atrial fibrillation- a 2-center experience. Circ J. 2017;81:974–80.CrossRef
14.
Zurück zum Zitat Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, et al. Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation. Int J Cardiol. 2018;266:106–11.CrossRef Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, et al. Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation. Int J Cardiol. 2018;266:106–11.CrossRef
15.
Zurück zum Zitat Winkle RA, Jarman JWE, Mead H, Engel G, Kong MH, Fleming W, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score. Heart Rhythm. 2016;13:2119–25.CrossRef Winkle RA, Jarman JWE, Mead H, Engel G, Kong MH, Fleming W, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score. Heart Rhythm. 2016;13:2119–25.CrossRef
16.
Zurück zum Zitat Irfan G, de Asmundis C, Mugnai G, Poelaert J, Verborgh C, Umbrain V, et al. One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience. Europace. 2016;18:987–93.CrossRef Irfan G, de Asmundis C, Mugnai G, Poelaert J, Verborgh C, Umbrain V, et al. One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience. Europace. 2016;18:987–93.CrossRef
17.
Zurück zum Zitat Yalin K, Abdin A, Lyan E, Sawan N, Liosis S, Elsner C, et al. Safety and efficacy of persistent atrial fibrillation ablation using the second-generation cryoballoon. Clin Res Cardiol. 2018;107(7):570–7.CrossRef Yalin K, Abdin A, Lyan E, Sawan N, Liosis S, Elsner C, et al. Safety and efficacy of persistent atrial fibrillation ablation using the second-generation cryoballoon. Clin Res Cardiol. 2018;107(7):570–7.CrossRef
18.
Zurück zum Zitat Kubala M, Hermida JS, Nadji G, Quenum S, Traulle S, Jarry G. Normal pulmonary veins anatomy is associated with better AF-free survival after cryoablation as compared to atypical anatomy with common left pulmonary vein. Pacing Clin Electrophysiol. 2011;34:837–43.CrossRef Kubala M, Hermida JS, Nadji G, Quenum S, Traulle S, Jarry G. Normal pulmonary veins anatomy is associated with better AF-free survival after cryoablation as compared to atypical anatomy with common left pulmonary vein. Pacing Clin Electrophysiol. 2011;34:837–43.CrossRef
19.
Zurück zum Zitat Schmidt M, Dorwarth U, Straube F, Daccarett M, Rieber J, Wankerl M, et al. Cryoballoon in AF ablation: impact of PV ovality on AF recurrence. Int J Cardiol. 2013;167:114–20.CrossRef Schmidt M, Dorwarth U, Straube F, Daccarett M, Rieber J, Wankerl M, et al. Cryoballoon in AF ablation: impact of PV ovality on AF recurrence. Int J Cardiol. 2013;167:114–20.CrossRef
20.
Zurück zum Zitat Kencht S, Kuhne M, Altmann D, Ammann P, Schaer B, Osswald S, et al. Anatomical predictors for acute and mid-term success of cryoballoon ablation of atrial fibrillation using the 28mm balloon. J Cardiovasc Electrophysiol. 2013;24:132–8.CrossRef Kencht S, Kuhne M, Altmann D, Ammann P, Schaer B, Osswald S, et al. Anatomical predictors for acute and mid-term success of cryoballoon ablation of atrial fibrillation using the 28mm balloon. J Cardiovasc Electrophysiol. 2013;24:132–8.CrossRef
21.
Zurück zum Zitat Guler E, Guler GB, Demir GG, Kizilirmak F, Gunes HM, Barutcu I, et al. Effect of pulmonary vein anatomy and pulmonary vein diameters on outcome of cryoballoon catheter ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2015;38:989–96.CrossRef Guler E, Guler GB, Demir GG, Kizilirmak F, Gunes HM, Barutcu I, et al. Effect of pulmonary vein anatomy and pulmonary vein diameters on outcome of cryoballoon catheter ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2015;38:989–96.CrossRef
22.
Zurück zum Zitat John RM, Kapur S, Ellenbogen KA, Koneru JN. Atrioesophageal fistula formation with cryoballoon ablation is most commonly related to the left inferior pulmonary vein. Heart Rhythm. 2017;14:184–9.CrossRef John RM, Kapur S, Ellenbogen KA, Koneru JN. Atrioesophageal fistula formation with cryoballoon ablation is most commonly related to the left inferior pulmonary vein. Heart Rhythm. 2017;14:184–9.CrossRef
23.
Zurück zum Zitat Furnkranz A, Bordignon S, Bohmig M, Konstantinou A, Dugo D, Perrotta L, et al. Reduced incidence of esophageal lesions by luminal esophageal temperature-guided second-generation cryoballoon ablation. Heart Rhythm. 2015;12:268–74.CrossRef Furnkranz A, Bordignon S, Bohmig M, Konstantinou A, Dugo D, Perrotta L, et al. Reduced incidence of esophageal lesions by luminal esophageal temperature-guided second-generation cryoballoon ablation. Heart Rhythm. 2015;12:268–74.CrossRef
24.
Zurück zum Zitat Leite LR, Santos SN, Maia H, Henz BD, Giuseppin F, Oliverira A, et al. Luminal esophageal temperature monitoring with a deflectable esophageal temperature probe and intracardiac echocardiography may reduce esophageal injury during atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol. 2011;4:149–56.CrossRef Leite LR, Santos SN, Maia H, Henz BD, Giuseppin F, Oliverira A, et al. Luminal esophageal temperature monitoring with a deflectable esophageal temperature probe and intracardiac echocardiography may reduce esophageal injury during atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol. 2011;4:149–56.CrossRef
25.
Zurück zum Zitat Neumann T, Vogt J, Schumacher B, Dorszewski KM, Hans N, et al. Circumferential pulmonary vein isolation with the cryoballoon technique. Results from a prospective 3-center study. J Am Coll Cardiol. 2008;52:273–8.CrossRef Neumann T, Vogt J, Schumacher B, Dorszewski KM, Hans N, et al. Circumferential pulmonary vein isolation with the cryoballoon technique. Results from a prospective 3-center study. J Am Coll Cardiol. 2008;52:273–8.CrossRef
26.
Zurück zum Zitat Metzner A, Rausch P, Lemes C, Reissmann B, Bardyszewski A, Tilz R, et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28mm cryoballoon. J Cadiovasc Electrophysiol. 2014;25:466–70.CrossRef Metzner A, Rausch P, Lemes C, Reissmann B, Bardyszewski A, Tilz R, et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28mm cryoballoon. J Cadiovasc Electrophysiol. 2014;25:466–70.CrossRef
27.
Zurück zum Zitat Mugnai G, de Asmundis C, Ciconte G, Irfan G, Saitoh Y, Velagic V, et al. Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation: a large single-center study of 500 consecutive patients. Heart Rhythm. 2015;12(7):1476–82.CrossRef Mugnai G, de Asmundis C, Ciconte G, Irfan G, Saitoh Y, Velagic V, et al. Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation: a large single-center study of 500 consecutive patients. Heart Rhythm. 2015;12(7):1476–82.CrossRef
28.
Zurück zum Zitat Ghosh J, Sepahpour A, Chan KH, Singarayar S, McGuire MA. Immediate balloon deflation for prevention of persistent phrenic nerve palsy during pulmonary vein isolation by balloon cryoablation. Heart Rhythm. 2013;10(5):646–52.CrossRef Ghosh J, Sepahpour A, Chan KH, Singarayar S, McGuire MA. Immediate balloon deflation for prevention of persistent phrenic nerve palsy during pulmonary vein isolation by balloon cryoablation. Heart Rhythm. 2013;10(5):646–52.CrossRef
29.
Zurück zum Zitat Meissner A, Maagh P, Christoph A, Oernek A, Plehn G. ECG-guided surveillance technique in cryoballoon ablation for paroxysmal and persistent atrial fibrillation: a strategy to prevent from phrenic nerve palsy. Int J Med Sci. 2016;13(6):403–11.CrossRef Meissner A, Maagh P, Christoph A, Oernek A, Plehn G. ECG-guided surveillance technique in cryoballoon ablation for paroxysmal and persistent atrial fibrillation: a strategy to prevent from phrenic nerve palsy. Int J Med Sci. 2016;13(6):403–11.CrossRef
Metadaten
Titel
Long-term outcomes of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation in Chinese patients
verfasst von
Ngai-Yin Chan
Chi-Chung Choy
Ho-Chuen Yuen
Hoi-Fan Chow
Ho-Fai Fong
Publikationsdatum
23.04.2019
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2020
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-019-00542-x

Weitere Artikel der Ausgabe 3/2020

Journal of Interventional Cardiac Electrophysiology 3/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.